Brain (and spinal cord) tumours
Open
Phase 1
This study is looking at a targeted treatment called 123I-ATT001 for a type of brain tumour called that has come back after treatment.
Recruitment start: 4 July 2024
Recruitment end: 30 October 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Mulholland
Theragnostics Limited, an Ariceum company
Last reviewed: 28 January 2025
CRUK internal database number: 19962